Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DONANEMAB-AZBT vs DORIPENEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DONANEMAB-AZBT vs DORIPENEM: Safety Overview

Metric DONANEMAB-AZBT DORIPENEM
Total FAERS Reports 1,018 239
Deaths Reported 18 78
Death Rate 1.8% 32.6%
Hospitalizations 117 91
Average Patient Age 74.6 yrs 56.2 yrs
% Female Patients 58.6% 35.4%
FDA Approval Date N/A Oct 12, 2007
Marketing Status Prescription Discontinued